In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
StressGen Initiates Phase II clinical trial of HspE7
Stressgen and Roche broaden heat shock protein agreement to maximize value of HspE7
Onyx granted European patent for cancer therapy
Austrian Nordic granted ProCon patent
StressGen and Genzyme Molecular Oncology buy out investor
Helix BioPharma granted drug delivery patent
Aphton granted anti- GnRH patent
MorphoSys Strengthens Patent Position on its Core HuCAL Technology in Europe
Digene gets European patent for novel Hybrid Capture technology